Lauren Block is a general internist and clinician educator. Her research interests include trainee wellness, interprofessional education, and curriculum development. She sees patients in primary care, precepts residents, and teaches epidemiology, communication, physical diagnosis, and clinical reasoning at Hofstra Northwell School of Medicine.

Dr. Block’s focus is on curriculum development in undergraduate medical education, building interprofessional educational programs, the patient centered medical home, and the move to electronic prescribing.

Current projects include the following:

1. Primary care perspectives on iStop (NY State Prescription Drug Monitoring Program)
2. Building awareness of healthcare teams among medical students and nurses
3. Design of a PD-ultrasound curriculum for medical students
4. Development of a patient experience module for medical students
5. Resident attainment of Patient Centered Medical Home EPAs
6. Real patients as teachers of medical students
7. An evaluation of IMPACcT (Improving Patient Access Care and cost through Training).

Johns Hopkins Bloomberg School of Public Health
Degree: MPH
2012

Harvard Medical School
Degree: MD
2008

Yale University
Degree: BS
2003

2016 TEACH Scholar, Society of General Internal Medicine
2016 Educational Innovations Poster Award, Mid-Atlantic SGIM meeting
2014-2015 High Potential Mentor, Arnold P Gold MAP-IT Grant
2014 General Internal Medicine Nominee, Spielman Award for Excellence in Research
2014 Hamolsky Finalist, National SGIM Meeting
2014 Finalist, Innovations Section, Society of Hospital Medicine Annual Meeting
2013 APDIM Spring Meeting Award of Excellence for Research Abstract
2013 Educational Innovations Poster Award, Mid-Atlantic SGIM meeting
2012 MPH Capstone Award, Johns Hopkins Bloomberg School of Public Health

1. Block L, Morgan-Gouveia M, Kelly W, Kannarkat M, Chretien KC, Cayea D. “Participation of medical students in discharge tasks: A needs assessment.” Journal of the American Geriatric Society. 2015;63(10):2181-3.
2. Block L, Jarlenski M, Wu AW, Feldman L, Conigliaro J, Swann J, Desai SV. “Inpatient safety outcomes following the 2011 residency work hour reform.” Journal of Hospital Medicine. 2014;9(6):347-52.
3. Block L, Pitts S (co-first authors), Perl TM. “Barriers and facilitators of implementation of a mandate for influenza vaccination among health-care personnel.” Infection Control and Hospital Epidemiology. 2014;35(6):724-7.
4. Block L, Cook B, Langley A, De La Torre D, Rogers MM, Noronha G, Sylvia M. “Coverage isn’t enough: Building primary care capacity in the setting of health reform.” Journal of Healthcare for the Poor and Underserved. 2014;25(1):25-28.
5. Block L, Jarlenski M, Wu AW, Bennett W. “Did the 2009 U.S. Preventive Services Task Force Recommendation Reduce Mammography Use Among Women Ages 40-49?” Journal of General Internal Medicine. 2013;28(11):1447-53.
6. Block L, Habicht R, Wu AW, Desai SV, Wang K, Silva KN, Niessen T, Oliver N, Feldman L. “In the wake of the 2003 and 2011 duty hours regulations, how do internal medicine interns spend their time?” Journal of General Internal Medicine. 2013; 28(8): 1042-7.

View more at PubMed

Dr. Leonid Poretsky graduated from First (Pavlov) Medical Institute in Leningrad, Russia (now St. Petersburg State Medical University), cum laude in 1977. He completed a fellowship in endocrinology and metabolism at Boston’s Beth Israel Hospital (now Beth Israel/Deaconess Medical Center) and a research fellowship at Harvard Medical School (1983–1985). He is professor of medicine at Hofstra Northwell School of Medicine and Chief of the Division of Endocrinology at Lenox Hill Hospital in New York City, a member of the Northwell Health System. His research interests include mechanisms of insulin action in the ovary, endocrinological aspects of AIDS and clinical outcomes in diabetes. He has authored over 100 publications and has served on the National Institutes of Health review committees and on the editorial boards of the Journal of Clinical Endocrinology and Metabolism and other endocrine journals.

While working as a research fellow at Harvard in the early 1980s, Dr. Poretsky became known for discovering, describing and characterizing insulin receptors in the human ovary. Dr. Poretsky’s finding established the ovary as a target for regulation by insulin, and introduced a new paradigm of the gonadotropic function of insulin. Poretsky had initially been researching the causes of hyperandrogenism in patients with extreme forms of insulin resistance, for example in women with insulin receptor gene mutations. Subsequently, his work became important for understanding more common disorders, such as polycystic ovary syndrom (PCOS), which affects up to 10% of reproductive age women and is associated with infertility and diabetes. Dr. Poretsky’s work helped lead to the use of insulin-sensitizing agents in patients with PCOS. Dr. Poretsky and his co-workers also characterized related receptors in the ovary (insulin-like growth factor receptors, peroxisome-proliferator activated receptor-gamma), and he conceptualized the insulin-related ovarian regulatory system.

Dr. Poretsky’s other research intents include clinical studies in diabetes and endocrinological aspects of HIV-infection. Current studies involve laboratory work on the efforts of a recently discovered hormone, irisin, in the reproductive system, the poential role of Vitamin D in preventing type 2 diabetes; and developing clinical strategies to reduce readmission rates in patients with diabetes.

First Medical Institute, Leningrad, Russia
Degree: MD
1977

Dimitar Avtanski, PhD
Email: davtanski@northwell.edu
Phone: (212) 434-2971

1. Seto-Young D, Avtanski D, Strizhevsky M, Parikh G, Patel P, Kaplun J, Holcomb K, Rosenwaks Z, Poretsky L. “Interactions among peroxisome proliferator activated receptor-g, insulin signaling pathways, and sterodogenic acute regulatory protein in human ovarian cells.” J Clin Endocrinol Metab 92:2232-2239, 2007.
2. Poretsky L, Song L, Brillon DJ, Ferrando S, Chiu J, McElhiney M, Ferenczi A, Sison C, Haller I, Rabkin J. “Metabolic and hormonal effects of oral DHEA in premenopausal women with HIV infection.” Hormone and Metabolic Research 41:244-249, 2009.
3. Parikh G, Varadinova M, Suwandhi P, Araki T, Rosenwaks Z, Poretsky L, Seto-Young D. “Vitamin D regulates steroidogenesis and insulin-like growth factor binding protein-1 (IGFBP-1) production in human ovarian cells.” Horm Metab Res 42:754-757, 2010.
4. Seto-Young D, Avtanski D, Varadinova M, Park A, Suwandhi P, Parikh G, Poretsky L. “Differential roles of MAPK-Erk1/2 and MAPK-p38 in insulin or insulin-like growth factor-I (IGF-I) signaling pathways for progesterone production in human ovarian cells.” Horm Metab Res 43: 386-390, 2011.
5. Seto-Young D, Avtanski D, Varadinova M, Park A, Suwandhi P, Parikh G, Poretsky L. “Differential roles of MAPK-Erk1/2 and MAPK-p38 in insulin or insulin-like growth factor-I (IGF-I) signaling pathways for progesterone production in human ovarian cells.” Horm Metab Res 43: 386-390, 2011.
6. Poretsky L. “Polycystic ovary syndrome:  Increased or preserved ovarian sensitivity to insulin?”  J Clin Endocrinol Metab 91:2859-2860, 2006.
7. Principles of diabetes mellitus, 2nd edition.  L. Poretsky, editor.  Springer, New York, 2010.

View more at PubMed

Dr. Marder is an attending physician with the Division of Rheumatology and she is involved in many clinical trials relating specifically to myositis as well as other autoimmune diseases.

Rheumatology
Inflammatory muscle disease
Vasculitis
Systemic lupus erythematosus

Hospital for joint Disease NYU
Degree: Fellowship
1999

North Shore Univeristy Hospital, Forest Hills
Degree: Resident
1997

Novosibirsk State Medical School
Degree: MD
1987

2015 GlaxoSmithKline IIS Award

1. Rothwell S et al and Myositis Genetics Consortium. “Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic background for many clinical subgroups.” Ann Rheum Dis. Sep 11, 2015
2. Yzadany J, Erkan D, Sanchez-Guerrero J, Hahn B, Levine A, Marder G, McCune J, Joseph W Post-Marketing experience with Belimumab in US lupus centers: data from The Lupus Clincial Trials Consortium, Inc. (LCTC) National Patient Registry. Arthritis & Rheumatism, Volume 65, October 2013 Abstract Supplement
3. Chester V. Oddis, Ann M. Reed, Rohit Aggarwal, Lisa G. Rider, Dana P. Ascherman, Marc C. Levesque, Richard J. Barohn, Brian M. Feldman, Michael O. Harris-Love, Diane C. Koontz, Noreen Fertig, Stephanie S. Kelley, Sherrie L. Pryber, Fredrick W. Miller, Howard E. Rockette and the RIM Study Group. “Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: A randomized, placebo-phase trial.” Arthritis Rheum. February 2013, v65, issue 2, p314-324.
4. Aggarwal R, reed AM, Ascherman DP, Barohn RJ, Feldman BM, Miller FW, Rider LG, Harris-Love M, Levesque M, Oddis C, the RIM Study Group. “Clinical and serologic predictors of response in Rituximab-treated refractory adult and juvenile dermatomyositis (DM) and adult polymyositis (PM) – the RIM Study.” Arthritis Rheum 2012; 64 Suppl 10 : 1598
5. Katzap E, Barilla-Labarca ML, Marder G. “Antisynthetase syndrome.” Curr Rheumatol Rep. 2011 Jun; 13(3): 175-81.
6. C Tseng, J Buyon, M Kim, HM Belmont, M MacKay, B Diamond, G Marder, P Rosenthal, K Haines, VIlie, S Abramson. “Moderate Dose Steroids Prevent Severe Flares in a Prospective Mulitcenter Study of Serlogoically Active Clinically Stable Systemic Lupus Erythematosus (SLE) patients.” Arthritis & Rheumatism, 2006, vol54, No 11.pp3623-3632
7. Belostosky O, Diamond A, Marder G. “TNF-Alpha inhibitors in treatment of refractory sarcoidosis with severe CNS Involvement: 65.” Journal of Allergy & Clinical Immunology. 115(2) Supplement 1:S17, February 2005.
8. Marder G and Greenwald RA. “Potential applications of matrix metalloproteinase inhibitors (MMPIs) in geriatric practice.” The Israel Medical Association Journal 2003; 5(5) 361-364.
9. Anita K, Marder G, Mattana J. “Severe upper airway obstruction from cricoartenoiditis as the sole presenting manifestation of a Systemic Lupus Erythematosus Flare.” Chest. 12193):990-993, March 2002.
10. Clancy R, Marder G, Martin V, Belmont HM, Abramson S, Buyon J. “Circulating activated endothelial cells in Systemic Lupus Erythematosus: further evidence for diffuse vasculopathy.” Arthritis & Rheumatism. 44(5):1203-1208, May 2001.
11. Marder, G; Buyon, J; Belmont, M; Abramson, SB; Clancy, R. “Circulating Activated Endothelial Cells in SLE: Further Evidence for Diffuse Vasculopathy.” Arthritis & Rheumatism. 42(9) Supplement, S306, September 1999.

View more at PubMed

Dr. Carney’s specialty is Geriatric and Palliative Medicine. She is Chief of the Division of Geriatric and Palliative Medicine in the Department of Medicine and an Associate Professor of Medicine at Hofstra Northwell School of Medicine. Dr. Carney is an internist, geriatrician and palliative care physician with public health experience. She is the first known geriatrician to serve as commissioner of a health department in New York State.

Dr. Carney received her medical degree from New York Medical College, completed her residency training in Internal Medicine at New York Presbyterian Hospital-Weill/Cornell Medical Center and fellowship in Geriatric Medicine at The Mount Sinai School of Medicine in New York City. She has dedicated her career to longevity promotion and advocacy for vulnerable populations.

Advanced Care Planning
Vulnerable Populations
Capacity Assessment
Shared Decision Making
Elder Abuse
Palliative Medicine

New York Medical College
Degree: MD

Weill Cornell Medical College-New York Hospital
Degree: Residency
Field of Study: Internal Medicine

Geriatric Medicine-Mount Sinai School of Medicine
Degree: Fellowship

2014 North Shore-LIJ Katz Institute for Women’s Health Sharon Joyce Schlanger Award for Outstanding Community Service
2013 North Shore-LIJ Health System President’s Award Finalist, Project Coastal Care
2013 Sustainable Long Island’s Getting It Done Award, North Shore-LIJ Project Coastal Care, Hurricane Sandy Community Response
2013 Energeia Partnership at Molloy College, for dedication to regional leadership and ongoing commitment to service
2011 New York State Association of County Health Officials Public Health Professional of the Year
2010 BOCES Nassau County Council of School Superintendents Award for H1N1 Efforts
2010 National Public Health Leadership Development Network, Balderson Leadership Project Award, Runner-up for Establishing a Special Needs Alert System Registry for Emergency Notifications, Northeast Public Health Leadership Institute, Albany, New York
2010 Balto Award in Response to H1N1 Pandemic Outbreak, New York State Department of Health
2003 Outstanding Community Physician Award, Hospice Care Network of Long Island
1998 Fellow of the Year Award, Mount Sinai School of Medicine and Medical Center, Department of Geriatrics
1992 William Cullen Bryant Award for Distinguished Academic Record and Outstanding Service to New York Medical College
1989 Outstanding Community Service Award, New York Medical College

1. Emmert BE Jr, Rimar A, Carney MT. “Flying the Unfriendly Skies: A Case Report.” Air Med J. 2016 Jul-Aug;35(4):251-2. doi: 10.1016/j.amj.2016.04.003. Epub 2016 May 25.
2. Barginear MF, Kozikowski A, Pekmezaris R, Akerman M, Gopal N, Goldberg B, Carney MT, Wolf-Klein G. “Perceptions of Older Adults, Hematologists, and Medical Oncologists in Cancer Care.” South Med J. 2016 Apr;109(4):258-64. doi: 10.14423/SMJ.0000000000000446.
3. Carney MT, Buchman T, Neville S, Thengampallil A, Silverman R. “A community partnership to respond to an outbreak: a model that can be replicated for future events.” Prog Community Health Partnersh. 2014 Winter;8(4):531-40. doi: 10.1353/cpr.2014.0065.
4. Lien C, Raimo J, Abramowitz J, Khanijo S, Kritharis A, Mason C, Jarmon CH, Nash IS, Carney MT. “Community healthcare delivery post-Hurricane Sandy: lessons from a mobile health unit.” J Community Health. 2014 Jun;39(3):599-605. doi: 10.1007/s10900-013-9805-7.
5. Dlugacz Y, Fleischer A, Carney MT, Copperman N, Ahmed I, Ross Z, Buchman T, Fried AM, Cabello C, De Geronimo M, Sweetapple C, Besthoff CM, Silverman RA. “2009 H1N1 vaccination by pregnant women during the 2009-10 H1N1 influenza pandemic.” Am J Obstet Gynecol. 2012 Apr;206(4):339.e1-8. doi: 10.1016/j.ajog.2011.12.027. Epub 2011 Dec 30.
6. Gershon RR, Magda LA, Qureshi KA, Riley HE, Scanlon E, Carney MT, Richards RJ, Sherman MF. “Factors associated with the ability and willingness of essential workers to report to duty during a pandemic.” J Occup Environ Med. 2010 Oct;52(10):995-1003. doi: 10.1097/JOM.0b013e3181f43872.
7. Adams EH, Scanlon E, Callahan JJ 3rd, Carney MT. “Utilization of an incident command system for a public health threat: West Nile virus in Nassau County, New York, 2008.” J Public Health Manag Pract. 2010 Jul-Aug;16(4):309-15. doi: 10.1097/PHH.0b013e3181bb8392.
8. Foldi NS, Schaefer LA, White RE, Johnson R Jr, Berger JT, Carney MT, Macina LO. “Effects of graded levels of physical similarity and density on visual selective attention in patients with Alzheimer’s disease.” Neuropsychology. 2005 Jan;19(1):5-17.
9. Carney MT, Kahan FS, Paris BE BE. “Elder abuse: is every bruise a sign of abuse?” Mt Sinai J Med. 2003 Mar;70(2):69-74.

View more at PubMed

Dr. Pilapil is a primary care physician, dual-trained in internal medicine and pediatrics. Her interests include the care of both children and adults with special health care needs, in particular their transition from pediatric- to adult-oriented care.

Dr. Pilapil’s primary research focus is on young adults with special health care needs, particularly those with conditions originating in childhood. Her research focus is aimed at identifying opportunities to improve care of this patient population (including the importance of preventative care) and to increase provider comfort in caring for these patients.

Icahn School of Medicine at Mount Sinai
Degree: MPH
2014

Icahn School of Medicine at Mount Sinai
Degree: MD
2009

Harvard University
Degree: BA
2005

2014 SGIM David E. Rogers Junior Faculty Education Award

1. Pilapil M, Morris L, Saito K, Kouya F, Maku V, Kwalar R, Palmer N, Tih PM, Jao J. “Retrospective analysis of the prevalence of and factors associated with condom use among young HIV-infected women in Cameroon.” SAGE Open Med. 2016 Jan 14;4:2050312115626432. doi: 10.1177/2050312115626432. eCollection 2016.

2. Pilapil M, DeLaet D. “Health risk behaviors in adolescents and young adults with special health care needs.” Curr Opin Pediatr. 2015 Feb;27(1):132-7. doi: 10.1097/MOP.0000000000000177. Review.

3. Morris L, Kouya F, Kwalar R, Pilapil M, Saito K, Palmer N, Posada R, Tih PM, Welty T, Jao J. “Factors associated with inconsistent condom use in adolescents with negative or unknown HIV status in Northwest Cameroon.” AIDS Care. 2014;26(11):1440-5. doi: 10.1080/09540121.2014.920948. Epub 2014 May 27.

4. Järvinen KM, Konstantinou GN, Pilapil M, Arrieta MC, Noone S, Sampson HA, Meddings J, Nowak-Węgrzyn A. “Intestinal permeability in children with food allergy on specific elimination diets.” Pediatr Allergy Immunol. 2013 Sep;24(6):589-95. doi: 10.1111/pai.12106. Epub 2013 Aug 2.

View more at PubMed

Dr. Zhang is currently an Associate Research Statistician at Feinstein Institute for Medical Research, Northwell Health. She collaborates with the physicians, fellows and other researchers in Department of Medicine, North Shore University Hospital in their medical research. Specifically, she provides statistical consulting services and perform statistical duties including study design, data management, data manipulation and statistical analysis.

Dr. Zhang writes statistical sections for protocols, grant applications and medical papers. She also develops statistical methodologies to solve unique statistical problems. Previously, she was a Biostatistician at the Department of Medicine, Hospital for Special Surgery and Associate Research Scientist at New York University School of Medicine. She obtained her PhD in Biostatistics from the Department of Population Health, at New York University.

Dr. Zhang’s research interest includes multilevel modelling, longitudinal analysis, survival analysis, clinical trials, meta-analysis and machine learning. Currently, She conducts research about linking US Census Bureau census-tract level socioeconomic data with patient level data simply by patient addresses, to identify risk factors at both levels for treatment outcomes through multilevel models. She is also conducting research in capture-recapture modeling to estimate the population size of certain diseases in defined areas and the population mean of covariates.

New York University
Degree: PhD
2011
Field of Study: Biostatistics

Washington State University
Degree: MS
2005
Field of Study: Statistics

University of New Brunswick
Degree: MA
2003
Field of Study: Economics

Nankai University
Degree: BA
2001
Field of Study: Economics

2005-2011 Fellowship, Division of Biostatistics, New York University, New York, NY

1. Lisa A. Mandl, Ting-Jung Pan, Meng Zhang, Tina Bailey, Eric Greenberg, Mayu Sasaki, Patricia Quinlan, Michael Parks and Steven K. Magid. “Falls Among Hospitalized Orthopedic Patients: A Prospective Case-Control Study. Poster Presentation.” American Academy of Orthopaedic Surgeons. Orlando, FL. March 1-5, 2016
2. Goodman, Susan, Mandl, Lisa, Parks, Michael, Zhang, Meng, McHugh, Kelly, Lee, You-Yu, Nguyen, Joseph, Russell, Linda, Bogardus, Margaret, Figgie, Mark, Bass, Anne. “Disparities in Total Knee Arthroplasty Outcomes: Census Tract Data Demonstrates Strong Interactions between Race and Poverty.” Arthritis & Rheumatology, Forthcoming, 2015
3. Gordon JK, Girish G, Berrocal V, Zhang M, Hatzis C, Assassi S, Bernstein E, Domsic RT, Hant FN, Hinchcliff M, Schiopu E, Steen V, Frech T, Khanna. “Reliability and Validity of the Tender and Swollen Joint Counts and Modified Rodnan Skin Score in Early Diffuse Cutaneous Systemic Sclerosis.” Arthritis Care & Research, Forthcoming, 2015
4. Susan M. Goodman, Beverly Johnson, Meng Zhang, Wei-Ti Huang, Rebecca Zhu, Mark Figgie, Michael Alexiades and Lisa A Mandl. “Rheumatoid Arthritis Patients have Similar Excellent Outcomes after Total Knee Replacement Compared with Osteoarthritis Patients.” The Journal of Rheumatology, January 2016; 43(1):46-53.
5. So-Young Kim, Meng Zhang, Richard Bockman. “Early Bone Marker Changes in Responders and Non-responders to Teriparatide.” Osteoporosis International. Forthcoming, 2015
6. Lisa A. Mandl, Rebecca Zhu, Meng Zhang, Wei-Ti Huang, Michael M. Alexiades, Mark P. Figgie, Susan M. Goodman. “Short Term Total Hip Arthroplasty Outcomes in Patients with Psoriatic Arthritis, Psoriatic Skin Disease, and Osteoarthritis.” Arthritis & Rheumatology, February 2016;68(2): 410-417

View more at PubMed

Dr. Sonali Narain is a board-certified rheumatologist with over 15 years of experience in rheumatology through her research and clinical experience. She currently serves as the Director of the Scleroderma and Raynaud Treatment Center and Epidemiology, Outcomes and Patient-Oriented Research in the Division of Rheumatology at Northwell Health.

Dr. Narain graduated from medical school in India and moved to the US for her Masters in Public Health-Epidemiology at the Univeristy of Florida, Gainesville, FL. It was here that her journey in rheumatology began. She initially worked in translational research in studying biomarkers in rheumatic diseases under the mentorship of Dr. Westley Reeves. She then moved to Massachussettes where she completed her Internal Medicine Residency training at Metrowest Medical Center, Framingham, MA. This was followed by a fellowship in rheumatology at Hospital for Special Surgery, New York NY. During her fellowship, under the mentorship of Dr. Jane Salmon, her research was focussed on characterizing the role of S1P dysregulation as a pathogenic factor in vascular injury in SLE. This proposal was awarded funding through the Empire Clinical Research Investigator Program (ECRIP) in 2014.

She has authored papers and textbook chapters and also presented at national meetings. She is an active member of the Americal College of Rheumatology (ACR).

Systemic lupus erythematosus
Sjogren’s syndrome
Systemic sclerosis

University of Florida College of Public health and Health Professions
Degree: MPH
2002

Sri Adichunchanagiri Institue of Medical Sciences
Degree: MBBS
2000

2011 Best Teaching Resident

1. Narain S, Furie R. “Update on clinical trials in systemic lupus erythematosus.” Curr Opin Rheumatol. 2016 Sep;28(5):477-87.
2. DeFilippis EM, Narain S, Sobol I, Narula N, Bass A, Erkan D. “Rapidly Progressive Cardiac Failure Due to Giant Cell Myocarditis: A Clinical Pathology Conference Held by the Division of Rheumatology at Hospital for Special Surgery.” HSS J. 2015 Jul; 11(2):182-6
3. Ramsden-Stein, D, Narain, S, Lockshin, MD. “Retiform purpura Initially Concerning for Granulomatosis with Polyangiitis” Grand Rounds from HSS, Management of Complex Cases, Fall 2012, Vol 3, Issue 3
4. Kakumanu P, Sobel ES, Narain S, Li Y, Akaogi J, Yamasaki Y, Segal MS, et al. “Citrulline dependence of anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus as a marker of deforming/erosive arthritis.” J Rheumatol. 2009 Dec;36(12):2682-90
5. Li Y, Lee PY, Sobel ES, Narain S, Satoh M, Segal MS, Reeves WH, Richards HB. “Increased expression of FcgammaRI/CD64 on circulating monocytes parallels ongoing inflammation and nephritis in lupus.” Arthritis Res Ther. 2009;11(1):R6.
6. Lee PY, Li Y, Richards HB, Chan FS, Zhuang H, Narain S, Butfiloski EJ, Sobel ES, Reeves WH, Segal MS, “Type I Interferon: A Novel Risk Factor for EPC Depletion and Endothelial Dysfunction in SLE.” Arthritis Rheum. 2007 Nov;56(11):3759-69
7. Kelly-Scumpia KM, Nacionales DC, Scumpia PO, Weinstein JS, Narain S, Moldawer LL, Satoh M, Reeves WH. “In vivo adjuvant activity of the RNA component of the Sm/RNP lupus auto antigen.” Arthritis Rheum. 2007 Sep 28;56(10):3379-3386
8. Yamasaki Y, Narain S, Yoshida H, Hernandez L, Barker T, Hahn PC, Sobel ES, Segal MS, Richards HB, Chan EKL, Reeves WH, Satoh M. “Autoantibodies to RNA helicase A: A new serological marker of early lupus.” Arthritis Rheum. 2007 Feb; 56 (2):596-604.
9. Yamasaki Y, Honkanen-Scott M, Hernandez L, Ikeda K, Barker T, Bubb MR, Narain S, Richards HB, Chan EK, Reeves WH, Satoh M. “Nucleolar staining cannot be used as a screening test for the scleroderma marker anti-RNA polymerase I/III antibodies.” Arthritis Rheum. 2006 Aug 31; 54(9):3051-3056
10. Li Y, Tucci M, Narain S, Barnes EV, Sobel ES, Segal MS, Richards HB. “Urinary biomarkers in lupus nephritis.” Autoimmun Rev. 2006 Jul; 5(6):383-8.

View more at PubMed

Dr. Schwartz is trained as a clinical psychologist and behavioral epidemiologist and, as such, her primary area of research interest lies in the intersection between mental health and physical health outcomes, particularly as it applies to ethnic minority and marginalized populations. Dr. Schwartz has a particular interest in how trauma experiences affect health and mental health outcomes, particularly among individuals with chronic illnesses such as HIV. She is a Principal Investigator on numerous federally and privately funded population-based studies that focus specifically on the impact of Hurricane Sandy on mental health. She also has a strong background in program design and evaluation with an emphasis on the measurement of psychosocial factors and the implementation and evaluation of community- and clinic-based programs with psychosocial components.

Contributions to the role of mental health and
abuse on HIV-related outcomes and STI/HIV-risk

Mental health difficulties and abuse have a strong impact on STI/HIV acquisition, transmission and progression, particularly among marginalized groups. Dr. Schwartz has conducted a number of research studies and published and presented extensively on the syndemic nature of violence, substance use, mental health and HIV among women, in particular. She was a co-investigator on the Women’s Interagency HIV Study (WIHS; NIAID U01), the largest ongoing natural history study of HIV in women in the US. In addition, she is a co-investigator on a number of SAMHSA funded projects that aim to reduce the mental health burden and HIV risk behavior among women at high risk for HIV. Dr. Schwartz has a strong interest in understanding the barriers to optimal adherence among people living with HIV and was a co-investigator on a SAMHSA-funded project that aimed to evaluate the obstacles to medication adherence in populations diagnosed with HIV/AIDS, with a focus on substance abuse reduction.

Contributions regarding how natural disasters
and other types of trauma impact mental health

Literature has indicated that victims of natural disasters are often at elevated risk for various types of mental health difficulties, however, little is known about the impact of natural disasters on the NYC metropolitan area that has been largely unaffected by natural disasters until Hurricane Sandy. Dr. Schwartz was the co-PI of a CDC-funded U01 that aimed to understand the impact of Hurricane Sandy on the mental health of adult residents of Long Island, Queens and Staten Island, NY. In addition, she is the PI of a foundation-funded award that seeks to understand this impact specifically among residents of the Rockaways, Queens (an area devastated by the hurricane) and to link interested residents into mental health care. She was a co-investigator on a NYS Block Grant (in Child Psychiatry) that sought to foster resilience and positive mental health among children and families in the Long Beach and Rockaways areas post Hurricane Sandy and my role was to evaluate the efficacy of the various intervention approaches being used. Finally, Dr. Schwartz is a co-investigator on three ASPR-funded grants that seek to examine resilience in our CDC funded cohort and to follow the cohort over time, to examine the efficacy of a stress reduction intervention among first responders involved with Hurricane Sandy, and to use public health surveillance data to better elucidate the mental health impact of the hurricane. This works has resulted in numerous abstracts, presentations and manuscripts.

Contributions regarding the impact of
lung cancer surgery on Quality of Life (QoL)

Given the sharp increase in early detection of lung cancer, patients and physicians are faced with numerous options regarding intervention for early stage lung cancer. Her research involving the impact of mental health on outcomes including quality of life in both HIV and cardiovascular disease as a co-investigator on a PCORI-funded project with the Department of Medicine investigating the impact of an intervention on patient outcomes including QoL, informed my interest in understanding these issues in lung cancer. Dr. Schwartz’s work in collaboration with Northwell Health clinicians as well as Mount Sinai Medical Center’s I-ELCAP investigators allowed me to conduct research on the impact of various types of surgery on QoL. In addition, she facilitated and conducted qualitative analysis on multiple focus groups involving thoracic surgeons and early stage lung cancer survivors which have resulted in manuscripts in preparation as well as invited lectures.

University of Illinois at Chicago
Degree: PhD
2004

University of Pennsylvania
Degree: BA
1996

Alexis Watson, BS
Project Coordinator
Email: awatson2@northwell.edu

Samantha Schneider, BA
Project Coordinator
Email: sschneide5@northwell.edu

2011 Best Teaching Resident

1. Schwartz RM, Mansoor A, Wilson TE, Anastos K, Everson-Rose SA, Golub ET, Goparaju L,  Hessol NA, Mack WJ, Lazar J (2011). “Chronic depressive symptoms and Framingham coronary risk in HIV-infected and HIV-uninfected women.” AIDS Care. 2011;24(3):394-403.
2. Schwartz RM, Weber KM, Schechter GE, Connors NC, Gousse Y, Young MA, Cohen MH. “Psychosocial correlates of gender-based violence among HIV-infected and HIV-uninfected women in three US cities.” J AIDS Patient Care STDs. 2014 May;28(5):260-7.
3. Schwartz RM, Yip R, Olkin I, Sikavi D, Taioli E, Henschke C. “Impact of surgery for stage IA non-small cell lung cancer on quality of life.” J Community and Supportive Oncology. 2016 Jan:14(1):37-44.
4. Schwartz RM, Liu B, Sison C, Kerath SM, Breil T, Murphy L, Taioli E. “Study design and results of a population-based study on perceived stress following Hurricane Sandy.” Disaster Medicine and Public Health Preparedness. 2016;10:325-332.
5. Schwartz RM, Sison C, Kerath SM, Murphy L, Breil T, Sikavi D, Taioli E. “The impact of Hurricane Sandy on the mental health of NY area residents.” American Journal of Disaster Medicine. 2015 Fall 10(4): 339-46.
6. Schwartz RM, Rothenberg P, Kerath SM, Liu B, Taioli E. “The lasting mental health effects of Hurricane Sandy on residents of the Rockaways.” J Emergency Management. 2016. In press.

View more at PubMed

Dr. Keith Sultan completed his residency in internal medicine and received postdoctoral training in gastroenterology from Lenox Hill Hospital. He left private practice seven and a half years ago with the primary goal to return to an academic environment and pursue his interests in teaching and Inflammatory Bowel Disease (IBD) research. Over the past several years especially, his goal to engage in meaningful IBD research has begun to take shape. He has developed a strong team of internal and external mentors in gastroenterology, patient centered research, and clinical research methods. He has a dedicated team of research assistants, statistical staff, and medical informatics team who have presented abstracts reporting the outcomes of their work at recent American College of Gastroenterology national meetings as well as for Digestive Disease Week.

Dr. Sultan has been an attending physician in the Division of Gastroenterology, Hepatology and Nutrition since 2009, and is an Assistant Professor of Medicine at Hofstra Northwell School of Medicine. In addition, Dr. Sultan has multiple Medical Attending appointments throughout the hospitals within the organization. Dr. Sultan’s professional memberships include the American Gastroenterological Association and the Crohn’s and Colitis Foundation of America. He is a fellow of the American College of Gastroenterology and serves on the College’s Archives Committee.

Dr. Sultan’s major research interests include Inflammatory Bowel Disease (IBD), i.e. Crohn’s Disease and Ulcerative Colitis. He is the Principal Investigator on multiple investigator initiated projects including those evaluating the relationship between IBD in different areas including opiate pain medication usage, opiate use indications, venous thromboembolism, microbiome analysis, dual therapy, disparities, myocardial infarction, C.dff infection, and fatty liver.

Dr. Sultan is also leading the effort to develop an IBD patient registry within Northwell and currently is creating a database with the help of the Bio-Informatics Department. His work is intended to solidify a structure and culture of high level IBD clinical care and research throughout the division and department. He is also the site primary investigator for several phase 3 therapeutic drug trials for both Crohn’s Disease and Ulcerative colitis.

State University of New York School of Medicine at Stony Brook
Degree: MD
1994

Union College
Degree: BS
1990

Benley George
Senior Research Coordinator
Email: bgeorge7@northwell.edu

Sundas Khan
Senior Research Coordinator
Email: skhan31@northwell.edu

Cailin Grant
Research Coordinator
Email: cgrant10@northwell.edu

2010-Present Fellow of the American College of Gastroenterology
2005 Leon Hess Memorial award for Fellowship Excellence Lenox Hill Hospital

1. Sultan K, Inamdar S, Hirten R. “The Uncertain Role of Immunomodulator Maintenance Following Cessation of anti-TNFα Therapy.” Clin Gastroenterol Hepatol. 2015 Jan 16. pii: S1542-3565(15)00040-3. doi: 10.1016/j.cgh.2015.01.006. [Epub ahead of print]
2. Rahman M, Akerman S, DeVito B, Miller L, Akerman M, Sultan K. “Comparison of the diagnostic yield and outcomes between standard 8 h capsule endoscopy and the new 12 h capsule endoscopy for investigating small bowel pathology.”  World J Gastroenterol. 2015 May 14;21(18):5542-7. doi: 10.3748/wjg.v21.i18.5542.  PMID:25987777
3. Axelrad J, Bernheim O, Colombel JF, Malerba S, Ananthakrishnan A, Yajnik V, Hoffman G, Agrawal M, Lukin D, Desai A, Mceachern E, Bosworth B, Scherl E, Reyes A, Zaidi H, Mudireddy P, DiCaprio D, Sultan K, Korelitz B, Wang E, Williams R, Chen L, Katz S, Itzkowitz S; “Risk of New or Recurrent Cancer in Patients With Inflammatory Bowel Disease and Previous Cancer Exposed to Immunosuppressive and Anti-Tumor Necrosis Factor Agents.” New York Crohn’s and Colitis Organization (NYCCO). Clin Gastroenterol Hepatol. 2015 Aug 3. pii: S1542-3565(15)01052-6. doi: 10.1016/j.cgh.2015.07.037. [Epub ahead of print] PMID:26247164
4. Hirten R, Sultan K, Thomas A, Bernstein DE. “Hepatic manifestations of non-steroidal inflammatory bowel disease therapy.” World J Hepatol. 2015 Nov 28;7(27):2716-28
5. Trindade AJ, Sultan K, Vamadevan AS, Fan C, Sejpal DV. “Successful use of volumetric laser endomicroscopy in imaging a rectal polyp.”  Therap Adv Gastroenterol.  2016 Jan; 9(1):128-131

View more at PubMed

Dr. Swaminath serves as the director of the Inflammatory Bowel Diseases Program at Lenox Hill Hospital. He is a practicing gastroenterologist with a clinical practice focused on treating patients with Crohn’s and colitis, a major contributor to the gastroenterology fellowship training program at Lenox Hill Hospital, and with an appointment as an Associate Professor in the School of Medicine at Hofstra University.

In addition to authoring numerous original clinical, translational, and review articles, Dr. Swaminath is a sought after speaker in the field of inflammatory bowel diseases. He has served as a NYC Crohn’s and Colitis Foundation Chapter Medical Advisory Committee chair and currently participates as a member of the national scientific advisory Professional Education Committee. He has been featured on television news, and numerous print and online media. He is a sought after speaker for Grand Rounds, patient societies, and teaching conferences.

Dr. Swaminath has a thriving multidisiplinary research program, involing both Phase III clinical trials to offer current edge biological therapy for patients with IBD unresponsive to standard therapy as well investigator initiated clinical projects in collaboration with the major medical centers in NYC.

Dr. Swaminath’s areas of interest include, diet in IBD, determining cause of death in IBD patients using the city and state department of health database, studying the best  treatments for IBD complicated by clostridium difficile, and management of iatrogenic injury in colitis patients. He has successfully served as a mentor to medical students, residents, MPH program graduates, and GI fellows with a strong track record of publication.

Mount Sinai School of Medicine
Degree: Fellowship
2008
Field of Study: IBD Research

University of California, San Diego
Degree: Fellowship
2007
Field of Study: Gastroenterology

University of California, San Diego
Degree: Residency
2004
Field of Study: Chief Medical Resident

University of California, San Diego
Degree: Residency
2003
Field of Study: Medicine

University of California, San Diego
Degree: MD
2000

Alexandra Feathers MPA, MPH
Research Associate

Isabel Roitman, NP

2013 Mentor at AGA Investing in the Future-Clinical Research in IBD, DDW
2012 Co-Chair: NY CCFA Chapter Medical Advisory Committee (ongonig)
2011 Columbia Summer Research Institute: Comparative Effectiveness Research Scholarship
2010 Ellen Scherl International Scholar Award
2006 ASGE Workshop on Achieving Academic Success, Washington D.C.
2006 Crohn’s & Colitis Foundation of America: IBD Fellowship, Mt. Sinai, NY
2006 Collaborations in IBD: A fellows mentoring program. Chandler, AZ
2005 AGA 11th Annual Methodologies in Healthcare Outcomes in Gastroenterology

1. Longman RA, Diehl G, Huh J, Swaminath, A, Miraldi E, Scherl E, Littman D.  “Microbiota Regulate CX3CR1+ Mononuclear Phagocytes to support Colitis-Associated Innate Lymphoid Cell Production of IL-22.” The Journal of Experimental Medicine 2014 Jul 28;211(8):1571-83.
2. Swaminath A, Bhadelia N, Wang C.  “Cost-Effectiveness of QuantiFERON prior to initiation of biologic therapy in inflammatory bowel disease.”  Inflammatory Bowel Disease Journal 2013, Aug 13.
3. Lior Latz, Javier P Gisbert, Beth Manoogian, Kirk Lin, Casper Steenholdt, Gerassimos J Mantzaris, Ashish Atreja, Yulia Ron, Arun Swaminath, Somal Shah, Alisa Hart, Peter Laszlo Lakatos, Pierre Ellul, Eran Israeli, Mads Naundrup Svendsen, C. Janneke van der Woude, Konstantinos H. Katsanos, Laura Yun, Epameinondas V. Tsianos,  Torben Nathan, Maria Abreu, Iris Dotan, Bret Lashner, Jorn Brynskov, Jonathan P. Terdiman, Peter Higgins, Maria Chaparro, Shomron Ben-Horin. “Doubling the infliximab dose versus halving the infusion intervals in Crohn’s disease patients with loss of response.” Inflammatory Bowel Disease Journal.  2012, Jan 31
4. Ting-Chin David Shen,; Benjamin Lebwohl; Himanshu Verma; Nikhil Kumta; Christina Tennyson,; Suzanne Lewis, MD1; Ellen Scherl; Arun Swaminath; Kristina Capiak; Dan DiGiacomo; Brian P. Bosworth; Thomas H. Brannagan III; Peter H.R. Green. “Peripheral Neuropathic Symptoms in Celiac Disease and Inflammatory Bowel Disease.” Journal of Clinical Neuromuscular Disease.  2012, Mar 13(3):137-145
5. Swaminath A, Lebwohl B, Capiak K, Present D. “Practice patterns in the use of anti-tumor necrosis factor alpha agents in the management of Crohn’s disease: A U.S. national practice survey comparing experts and non-experts.”  Digestive Diseases & Sciences. 2011 Apr 56(4):1160-64.
6. Swaminath A, Longstreth G, Runnman E, Yang Su-Jau. “Effect of physician education and patient counseling on inpatient percutaneous feeding tube placement rate, indications, and outcome.” Southern Medical Journal. 2010, Feb 103(2):126-130.
7. Swaminath A, Abreu M. “Early academic experience with the use of adalimumab in the treatment of Inflammatory bowel disease.” Alimentary Pharmacology & Therapeutics. 2009 Feb 1: 29(3):  273-8.
8. Swaminath A, Lichtiger S. “Infliximab injection for the treatment of colonic strictures due to Crohn’s disease.”  Inflammatory Bowel Diseases. 2008 Feb;14(2):213-6.
9. Kothari M, Mudireddy P, Swaminath A. “Patient Considerations in the management of ulcerative colitis – role of vedolizumab.” Therapeutics and Clinical Risk Management. 2015 Aug 19;11:1235-42
10. Hudesman D, Mazurek J, Swaminath A. “Capsule Endoscopy in Crohn’s Disease: Are we seeing any better?” World Journal of Gastroenterology 2014 Sept 28; 20(36): 13044-13051.
11. Swaminath A, Taunk R, Lawlor G. “Use of methotrexate in inflammatory bowel disease in 2014: A User’s guide.”  World Journal of Gastrointestinal Pharmacology & Therapeutics.  2014 Sept 6; 5(3):113-121.
12. Krishnareddy S, Swaminath A. “When combination therapy isn’t working: Emerging therapies for the management of inflammatory bowel disease.” World Journal of Gastroenterology. 2014 Feb 7; 20(5):1139-1146
13. Krishnareddy S, Swaminath A. “Update on the use of adalimumab in the management of Crohn’s disease.”  2013, Journal of Symptoms and Signs, Vol 2.
14. Longman  R, Swaminath A. “Microbial manipulation as primary therapy for Crohn’s disease.” World Journal of Gastroenterology, 2013 March 14; 19(10): 1513-1516.
15. Swaminath A, Present D. “Practical considerations in prescribing Anti-TNF therapy to your Crohn’s disease patients.” Visible Human Journal of Endoscopy. VHJOE.org  2011 (10): Issue 1
16. Swaminath A, Kornbluth A. “Use of video capsule endoscopy in Crohn’s disease.” Minerva gastroenterolgoica e dietologica.  2010 Dec; 56(4):437-49.
17. Swaminath A, Kornbluth A. “Video capsule endoscopy in inflammatory bowel disease: Past, Present, & Future Redux.” Inflammatory Bowel Diseases.  2010 (7): 1254-1262
18. Sharaiha R, Swaminath A. “A review of delayed release MMX-Mesalamine: It’s use in the treatment of ulcerative colitis.” Clinical Medicine: Therapeutics 2009 (1). 45-51
19. Swaminath A, Kornbluth A. “Optimizing drug therapy in inflammatory bowel disease.” Current Gastroenterology Reports 2007, 9:513-520

View more at PubMed

Steven Fishbane is the chief of nephrology of Northwell Health and Professor of Medicine at Hofstra Northwell Health School of Medicine. As a nephrologist with over 23 years of clinical experience and over 22 years as a medical researcher he understands and has studied many of the issues involved with patient hospitalizations, readmissions, complications of chronic kidney disease (CKD) and issues with decision making related to end stage kidney disease (ESKD). An important part of his training has been as medical director for 5 different dialysis facilities and as Medical Director for the Healthy Transitions in Advanced Kidney Disease Program. He has been the recipient of multiple honors and holds several appointments, including to the National Quality Forum’s Standing Committee of Admissions and Readmissions. Through his clinical research, Dr. Fishbane has become renowned for advancement and innovation in the treatment of CKD patients.

Dr. Fishbane received his MD and trained in nephrology at Albert Einstein College of Medicine. He has worked as a medical researcher for over 21 year, and has over 183 peer reviewed publications.

Hyperkalemia Management Complications of kidney disease
Inflammation in Kidney Disease
Quality management in Kidney Disease Anemia and Iron Management
Outcomes of kidney disease

Albert Einstein College of Medicine
Degree: MD
1988

Columbia University
Degree: Premedical Courses
1984

University of Miami
Degree: BBA
1981
Field of Study: Computer Science & Accounting

Azzour Hazzan
Associate Chairperson
Email: ahazzan@northwell.edu

Joy Jurnack
Research Nurse
Email: jjurnack@northwell.edu

Susan Mathew
Research Coordinator
Email: smathew@northwell.edu

Isabel Roitman, NP

2012 Nephrologist of the Year, American Kidney Fund
2007-present Castle Connelly Top Doctors
2004-Present Best Doctors
2003-2004 Best Doctors
2002-2003 Best Doctors
2002 Physician Leadership in Quality Improvement, IPRO
1998 Alpha Omega Alpha, Elected
1994 Outstanding Teaching Attending Award, Winthrop-University Hospital
1990 Outstanding Resident Award, Montefiore Hospital

1. Fishbane S, Masani NN, Hazzan AD. “Should target hemoglobin levels in dialysis patients be lowered to 9-10 g/dl?” Semin Dial. 2014 May-Jun;27(3):282-4. doi: 10.1111/sdi.12211. Epub 2014 Mar 25.
2. Jhaveri KD, Fishbane S. “Glomerular diseases: entering a new era.” Clin J Am Soc Nephrol. 2014 Mar;9(3):598-9. doi: 10.2215/CJN.06110613. No abstract available. PMID: 24607910
3. Villa M, Siskind E, Sameyah E, Alex A, Blum M, Tyrell R, Fana M, Mishler M, Godwin A, Kuncewitch M, Alexander M, Israel E, Bhaskaran M, Calderon K, Jhaveri KD, Sachdeva M, Bellucci A, Mattana J, Fishbane S, Coppa G, Molmenti E. “Shortened length of stay improves financial outcomes in living donor kidney transplantation.” Int J Angiol. 2013 Jun;22(2):101-4. doi: 10.1055/s-0033-1334139. PMID: 24436592 [PubMed] Free PMC Article
4. Siskind E, Sameyah E, Goncharuk E, Olsen EM, Feldman J, Giovinazzo K, Blum M, Tyrell R, Evans C, Kuncewitch M, Alexander M, Israel E, Bhaskaran M, Calderon K, Jhaveri KD, Sachdeva M, Bellucci A, Mattana J, Fishbane S, D’Agostino C, Coppa G, Molmenti E. “Removal of foley catheters in live donor kidney transplant recipients on postoperative day 1 does not increase the incidence of urine leaks.” Int J Angiol. 2013 Mar;22(1):45-8. doi: 10.1055/s-0033-1333870. PMID: 24436583
5. Masani N, Jhaveri KD, Fishbane S. “Update on membranoproliferative GN.” Clin J Am Soc Nephrol. 2014 Mar;9(3):600-8. doi: 10.2215/CJN.06410613. Epub 2014 Jan 9. PMID: 24408117

View more at PubMed

Dr. Hirsch’s clinical experience in infectious disease with a professional focus on medication safety and pharmaceutical utilization has led him to focus on prevention and treatment of infectious complications. My career includes board certification in Geriatric medicine as well as Infectious Diseases. During four years of practicing Geriatric medicine, he has been directly confronted by the enhanced vulnerability to infections in elderly debilitated persons. The evolution of infectious pathogens including antimicrobial resistance has been dramatic over two decades of clinical management of infectious diseases.

Dr. Hirsch’s immersion in clinical infectious disease with a leadership role in medication management in the hospital and health system as Chair of Pharmacy & Therapeutics Committee has given him a unique perspective. He has a record of accomplishment and experience in his current position. He has participated in studies evaluating the impact of copper surfaces on the bacterial bio-burden of patient care environments. Dr. Hirsch is fully committed to the goal of enhancing the safety of medical procedures and preventing spread of resistant bacterial pathogens.

Dr. Hirsch’s current research focus is on the role of the gut microbiome in health and disease. His clinical experience with fecal transplantation for recurrent Clostridium difficile infection has inspired additional areas of focus. Current research interests focus on the role of gut microbiome in health and disease. Projects in gut microbiome in patients with recurrent resistant urinary tract infections and a project that evaluates cytokine levels in patients with Non-Alcoholic Steatohepatitis and realtionship with gut microbiome and diet is currently in development. With ID fellows, a project that evaluates HIV patients with well controlled virus but low immune reconsitution is in early stages with plans to follow up published reasearch on gut microbiome correlates as well as a project evaluating impact of extended infusion of the antibiotic Cefoxitin for ESBL producing E coli urinary tract infections.

Cornell University
Degree: MD
1982

Wesleyan University
Degree: BA
1978

2014 Reviewer, Health Environments Research & Design Journal
2014 Innovator’s Award; Peggy Lillis Foundation, Fighting C diff through Education and Advocacy
2010 MDx Medical Inc.
2009 Compassionate Doctor certification on Vitals.com
2009 Top Doctor, Castle Connelly

1. Bharti S, Malhotra P, Hirsch B. “Acute intermittent porphyria precipitated by atazanavir/ritonavir.” Int J STD AIDS. 2016 Feb 11. pii: 0956462416633981. [Epub ahead of print] PMID: 26872826
2. Hirsch BE, Saraiya N, Poeth K, Schwartz RM, Epstein ME, Honig G. “Effectiveness of fecal-derived microbiota transfer using orally administered capsules for recurrent Clostridium difficile infection.” BMC Infect Dis. 2015 Apr 17;15:191. doi: 10.1186/s12879-015-0930-z. PMID: 25885020

View more at PubMed

Dr. Horowitz is involved with both NIH and industry sponsored research.

Rheumatoid Arthritis Novel Therapeutics
Comparative effectiveness
Medical decision making
Rheumatoid Arthritis therapeutic use
Shared decision making
Bone Health in Rheumatoid Arthritis
Research Specialty: Rheumatology

North Shore-LIJ Medical Center, New York Univeristy
Degree: Fellowship
2010

St. Vincent’s Catholic Medical Center, New York College of Medicine
Degree: Chief Resident
2008

St. Vincent’s Catholic Medical Center, New York College of Medicine
Degree: Residency
2007

State Univeristy of New York at Stony Brook College of Medicine
Degree: MD
2004

Univeristy of Pennsylvania
Degree: BA
2000

2000 BA Cum Laude

1. Horowitz, DL, Furie, RA. “Belimumab is Approved by the FDA: What More Do We Need to Know to Optimize Decision Making?” Curr Rheumatol Rep. 2012 DOI 10.1007/s11926-012-0256-4
2. Horowitz, DL, Furie, RA. “Does Belimumab Reduce Disease Activity in Adults with Systemic Lupus Erythrematosus?” Clinical Medicine Reviews in Therapeutics. 2012:4 71-78.
3. Horowitz, DL, Katzap, E, Horowtiz, S, Barilla-LaBarca, ML. “Approach to septic Arthritis.” Am Fam Physician. 84(6): 653-60. 2011.
4. Horowitz, DM and Furie, RA. “Abetimus Sodium: A Medication for the Prevention of Lupus Nephritis Flares.” Expert Opinion Pharmacotherapy. 10(9): 1501-7. 2009.
5. Korutla L, Wang PJ, Lewis DM, Neustadter JH, Stromberg MF, and Mackler SA. “Differences in Expressions, Actions and Cocaine Regulation of Two Isoforms for the Brain Transcriptional Regulator NAC-1.” Neuroscience. 110(3): 421-9, 2002.

View more at PubMed

Breast and GYN oncology

1. Cheng KL, Brody J, Warshall CE, Sloand EM, Allen SL. “Paroxysmal Nocturnal Hemoglobinuria Following Alemtuzumab Immunosuppressive Therapy for Myelodysplastic Syndrome and Complicated by Recurrent Life-Threatening Thrombosis Despite Anticoagulation: Successful Intervention with Eculizumab and Fondaparinux.”  Leukemia Research 2010; 34(4): e85-87.

View more at PubMed

Joseph P. McGowan, MD has provided HIV Primary Care to persons infected with HIV/AIDS for nearly 30 years. He is Board Certified in Infectious Diseases and Credentialed as an HIV Specialist by the American Academy of HIV Medicine (AAHIVM). He received a BA degree from Columbia University (summa cum laude), MD from the Mount Sinai School of Medicine and has completed a fellowship in Infectious Diseases and an NIH Fellowship in Immunology at the Albert Einstein College of Medicine.

Dr. McGowan is Professor of Medicine at the Hofstra Northwell School of Medicine and on faculty at the Albert Einstein School of Medicine. He is the chair of the New York/New Jersey Chapter Board of the American Academy of HIV Medicine. He has been the Director of HIV Ambulatory Care at the Bronx Lebanon Hospital Center and currently is Medical Director of the Center for AIDS Research & Treatment at the North Shore University Hospital on Long Island, NY. He has been involved in numerous HIV clinical trials for over 20 years.

Dr. McGowan has published over 60 original articles and abstracts dealing with HIV and AIDS. He is currently the Principal Investigator on over a dozen grant funded programs to provide HIV Primary Care and Prevention from the CDC, HRSA and New York State Department of Health. He serves as the Medical/Clinical Director of the AIDS Education and Training Regional Center at SUNY Stony Brook.

HIV and AIDS with a particular focus on HIV drug resistance, Management of HIV in Pregnancy, Anal Cancer Screening in HIV and the role of alteration in the microbiota in HIV immune reconstitution.

Mount Sinai School of Medicine
Degree: MD
1987

Columbia University
Degree: BA
1983

2015 World AIDS Day Award for Outstanding Provider, United Way of Long Island
2013 Best Doctors in America
2011 Elected Fellow in the Infectious Diseases Society of America
2010 America’s Top Doctors, Castle Connolly
2008 Attending Physician of the Year Award, North Shore University Hospital
2004 Elected Fellow in the American College of Physicians
1990 Leo M. Davidoff Society Award for Outstanding Achievement in the Training of Medical Students, Albert Einstein College of Medicine, Yeshiva University
1983 Phi Beta Kappa
1983 Summa Cum Laude

1. McGowan JP, Shah SS, Small CB, Klein RS, Schnipper SM, Chang CJ, Rosenstreich DL:  “Relationship of serum immunoglobulin and IgG subclass levels to race, ethnicity, and behavioral characteristics in HIV infection.” Med Sci Monit 12:1:CR11-16, 2005.
2. Shah SS, McGowan JP, Klein RS, Converse PJ, Blum S, Gourevitch MN: “Agreement Between Mantoux Skin Testing and QuantiFERON® -TB Assay Using Dual Mycobacterial Antigens in Current and Former Injection Drug Users.”  Med Sci Monit 12:4:MT11-16, 2006.
3. Alagappan K, McGowan J, DeClaro D, Ng D, Silverman RA.  “Tetanus Antibody Protection among HIV infected US born patients and Immigrants.”  International Journal of Emergency Medicine 1:123-126, 2008.
4. Gulick RM, Lalezari J, Goodrich J, Clumeck N, DeJesus E, Horban A, Nadler J, Clotet B, Karlsson A, Wohlfeiler M, Montana JB, McHale M, Sullivan J, Ridgway C, Felstead S, Dunne MW, van der Ryst E, Mayer H; MOTIVATE Study Teams (McGowan JP).  “Maraviroc for previously treated patients with R5 HIV-1 infection.” N Engl J Med. 2008 Oct 2;359(14):1429-41.
5. Fätkenheuer G, Nelson M, Lazzarin A, Konourina I, Hoepelman AI, Lampiris H, Hirschel B, Tebas P, Raffi F, Trottier B, Bellos N, Saag M, Cooper DA, Westby M, Tawadrous M, Sullivan JF, Ridgway C, Dunne MW, Felstead S, Mayer H, van der Ryst E; MOTIVATE 1 and MOTIVATE 2 Study Teams (McGowan JP).  “Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection.”  N Engl J Med. 2008 Oct 2;359(14):1442-55.
6. Chubineh S and McGowan J.  “Nausea and Vomiting in HIV: A Symptom Review.” Int J STD AIDS. 2008 Nov;19(11):723-8.
7. Cervia LD, McGowan JP. and Weseley AJ.  “Clinical and Demographic Variables Related to Pain in HIV-infected Individuals Treated with Effective, Combination Antiretroviral Therapy (cART).” Pain Medicine. 2010 Volume 11 Issue 4, Pages 498 – 503.
8. Sax PE, DeJesus E, Mills A, Zolopa A, Cohen C, Wohl D, Gallant JE, Liu HC, Zhong L, Yale K, White K, Kearney BP, Szwarcberg J, Quirk E, Cheng AK; GS-US-236-0102 study team.  “Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks.” Lancet. 2012 Jun 30;379(9835):2439-48. doi: 10.1016/S0140-6736(12)60917-9. Erratum in: Lancet. 2012 Aug 25;380(9843):730.
9. Nirupama Chandel, Hersh Goel, Mohammad Husain, Divya Salhan, Ashwani Malhotra, Joseph McGowan, and Pravin C. Singhal. “VDR hypermethylation and HIV-induced T cell loss.”  J Leukoc Biol. 2013 Apr;93(4):623-31.
10. DeJesus E, Rockstroh JK, Henry K, Molina JM, Gathe J, Ramanathan S, Wei X, Yale K, Szwarcberg J, White K, Cheng AK, Kearney BP; GS-236-0103 Study Team. “Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial.” Lancet. 2012 Jun 30;379(9835):2429-38. doi: 10.1016/S0140-6736(12)60918-0.
11. Griffin DO, Dharsee A, Rico JC, McGowan J: “The Increasing Frequency of Deaths Due to Malignancy in HIV+ Patients is Associated with Poor Viral Suppression, Low CD4 Counts, Decreased Vitamin D Levels and Integrase Inhibitor Therapy.”  Journal of Health Science 2014 2 (2014) 240-247. DOI: 10.17265/2328-7136/2014.05.005.
12. Chandel N, Ayosolla K, Lan X, Rai P, Mikulak J, Husain M, Malhotra A, McGowan J, and Singhal P. “Renin Modulates HIV Replication in T cells.” Journal of Leukocyte Biology 2014 Jun 26. pii: JLB.2A0414-192R. PMID: 24970860.
13. Griffin DO, Metzger M, Poeth K, Deng K, Dharsee A, Rico JC, McGowan J. “Malignancies, Particularly B-cell Lymphomas, are a Frequent Cause of Mortality in HIV-1 Patients Despite HAART.” Open Forum Infectious Diseases, 2:147, 2015.
14. Rico JC, Schwartz RM, McGowan J, Griffin DO (2015) “The Presence of a Malignant Comorbidity is a Significant Predictor of Increased 30-Day Hospital Readmission Rates in HIV-1 Infected Individuals.” J AIDS Clin Res 6: 532, 12/26/2015. doi:10.4172/2155-6113.1000532.
15. Griffin DO, Metzger MJ, Bharti S, Dharsee A, Rico JC, McGowan J. (2016) “Coinfection with Hepatitis C Virus Increases Mortality in HIV-1 Infected Patients through Increased Liver-Related Deaths Rather Than By Increasing Malignancy Related Deaths.” J AIDS Clin Res 7:558. doi:10.4172/2155-6113.1000558.

View more at PubMed

Research Specialty: Rheumatology
Research Interests: Psoriatic Arthritis; Spondyloarthropathy; Rheumatoid Arthritis

New York University Hospital for Joint Diseases
Degree: Fellowship
2006

New York University Medical Center
Degree: Chief Resident
2004

New York University Medical Center
Degree: Residency
2003

Upstate Medical Univeristy Syracuse College of Medicine
Degree: MD
2000

Cornell University
Degree: BS
2000

2012 Granted Membership in the Leo M. Davidoff Society which recognizes distinguished, caring and committed teaching of medical students, Albert Einstein College of Medicine
2007-2008 The Robert Manheimer Memorial Teacher of the Year Award in Rheumatology

1. Gross R, Schwartzman-Morris J, Krathen M, et al. “A Comparison of Malignancy Incidence among Psoriatic and Rheumatoid Arthritis Patients in a Large US Cohort.” Arthritis & rheumatology (Hoboken, NJ). 2014;66(6):1472-1481. doi:10.1002/art.38385.
2. Izmirly, P, Barisoni L, Buyon JP, Kim MY, Rivera TL, Schwartzman J, et al. “Expression of endothelial Protein C receptor (EPCR) in cortical peritubular capillaries associates with a poor clinical response in lupus nephritis.” Rheumatology (Oxford) 2009 48(5):513-519
3. Rubinstein T, Pitashny M. Levine B, Schwartz N, Schwartzman J, Weinstein E, Pego-Regiosa JM, Lu TY, Isenberg D, Rahman A, Putterman C. “Urinary neutrophil gelatinase-associated lipocalin as a novel biomarker for a disease activity in lupus nephritis.” Rheumatology (Oxford). 2010 49(5):960-971
4. Gindea S, Schwartzman J, Herlitz LC, Rosenberg M, Abadi J, Putterman C. “Proliferative Glomerulonephritis in Lupus Patients with a Human Immunodeficiency Virus Infection: A Difficult Clinical Challenge.” Semin Arthritis Rheum. 2010 Dec.

View more at PubMed

Dr. Tara Liberman’s speciality is Geriatric and Palliative Medicine. She is an Assistant Professor of Medicine at Hofstra Northwell School of Medicine and currently serves as the Associate Chief of the Division of Geriatric and Palliative Medicine overseeing both inpatient and outpatient clinical services. Dr. Liberman’s affiliation with Northwell Health dates back to when she was a medical student and rotated at North Shore University Hospital. She then completed an Internal Medicine residency, followed by a Geriatric Medicine fellowship with the health system. Dr. Liberman’s work is dedicated to caring and promoting academic efforts within an aging and vulerable population.

Dr. Liberman’s research interests revolve around goals of care in the advanced illness population. She has crossed non-conventional barriers including emergency medicine and pulmonary critical care, specifically cystic fibrosis. Dr. Liberman’s current endeavors include hospice evaluation in emergency medical rooms and transitions of care, as well as the integration of a geriatric trained social worker into the emergency room setting to improve available resources for the treatment of older adults. Dr. Liberman is also looking into the role of Palliative Care Medicine in both Oncology and Heart Failure initiatives. She is continually attempting to broaden exposure to Palliative Care Medicine throughout the wide continuum of modern medicine.

New York College of Osteopathic Medicine
Degree: DO
2001

North Shore University
Degree: Residency, Internal Medicine

North Shore University Hospital
Degree: Fellowship, Geriatric Medicine

2016 United Jewish Agency (UJA) Transitions of Care Grant
2015 Northwell Health Physician Leadership Program
2014 North Shore-LIJ President’s Award Nominee (ED/Palliative Care)
2012 Circle of Life Nominee: Celebrating Innovation in End of Life Care
2010 Harvard Palliative Care Faculty Development Grant

1. Ouchi K, Wu M, Medairos R, Grudzen CR, Balsells H, Marcus D, Whitson M, Ahmad D, Duprey K, Mancherje N, Bloch H, Jaffrey F, Liberman T. “Initiating palliative care consults for advanced dementia patients in the emergency department.” J Palliat Med. 2014 Mar;17(3):346-50. doi: 10.1089/jpm.2013.0285. Epub 2014 Jan 4.
2. Corrado-McKeon L, Saad M, Mir T, Liberman T, Cleary T, Lu C. “Treating persistent pain in the elderly: how do we proceed?” Consult Pharm. 2013 Aug;28(8):509-14. doi: 10.4140/TCP.n.2013.509.
3. Zaide GB, Pekmezaris R, Nouryan CN, Mir TP, Sison CP, Liberman T, Lesser ML, Cooper LB, Wolf-Klein GP. “Ethnicity, race, and advance directives in an inpatient palliative care consultation service.” Palliat Support Care. 2013 Feb;11(1):5-11. doi: 10.1017/S1478951512000417. Epub 2012 Jul 6.
4. Pekmezaris R, Cooper L, Efferen L, Mastrangelo A, Silver A, Eichorn A, Walia R, Mir T, Liberman T, Weiner J, Steinberg H. “Transforming the mortality review conference to assess palliative care in the acute care setting: a feasibility study.” Palliat Support Care. 2010 Dec;8(4):421-6. doi: 10.1017/S1478951510000283. Epub 2010 Sep 28.

View more at PubMed

Janice Wang serves as Director of the Adult Cystic Fibrosis Program and is Assistant Professor at Hofstra Northwell School of Medicine. Her clinical time is dedicated to in-patient pulmonary and critical care medicine as well as to the Department’s out-patient specialty practice encompassing adult cystic fibrosis (CF) care, as well as pulmonary and sleep medicine.

Dr. Wang graduated from Sophie Davis School of Biomedical Education, a 7-year program where she earned her Bachelor of Science degree from City College of New York and M.D. degree from SUNY Downstate, Brooklyn, New York. She completed her Internal Medicine residency training and Pulmonary, Critical Care & Sleep Medicine fellowships at Northwell Health and Hofstra Northwell School of Medicine.

Dr. Wang’s research interests include CF pharmaceutical research trials investigating new medicines targeting the abnormal Cystic Fibrosis Transmembrane Conductance Regulator protein responsible for the clinical manifestations of CF as well as antibiotic and airway clearance therapies for CF related lung disease. She is involved in a study focusing on advanced care planning in CF patients with severe disease and also hopes to initiate a web-based educational and support group, which is strongly desired in the CF community as infection control guidelines prohibit CF patients from being in close contact with each other. Additional interests include the medical rapid response system utilized when hospitalized patients are in need of critical care and the impact of a circadian lighting system on delirium in the medical intensive care unit. Dr. Wang has worked closely with the Cohen Children’s Hospital Pediatric Cystic Fibrosis Center as part of the OneCF Learning and Leadership Collaborative led by the Dartmouth Institute Microsystem Academy. This quality improvement project aimed to improve the transfer process of pediatric cystic fibrosis patients transitioning to the Adult CF Center.

SUNY Downstate College of Medicine, Brooklyn, NY
Degree: MD
2006

Sophie Davis School of Biomedical Education, New York, NY
Degree: BS
2004

2016 Cystic Fibrosis Foundation Center Grant
2015-2017 Cystic Fibrosis Foundation, Additional Research Coordinator Grant
2015 Long Island Jewish Service Guild Award, Research Grant, Assessment of Circadian Lighting on Delirium in the Medical Intensive Care Unit
2015 Cystic Fibrosis Foundation, Advanced Care Planning Grant, Informed Choices: A Decision Aid to Inform Shared Advanced Care Planning, Primary Investigator Negin Hajizadeh, Sub-Investigator Janice Wang
2015 Cystic Fibrosis Foundation Therapeutics, Therapeutics Development Center Grant, Primary Investigator Joan Decelie-Germana, Sub-Investigator Janice Wang
2013 Northwell Health Academic Day Competition, 1st place for Clinical Research Poster
2013 Scherr Award Honorable Mention
2012-2014 Cystic Fibrosis Foundation Program for Adult Care Excellence Grant
2010 Travel Award to ACCP Fellow’s Conference
2009 Northwell Health Academic Competition, 2nd place for Medical Education Poster

1. Morgenstern M, Wang J, Beatty N, Batemarco T, Sica A, Greenberg H. “Obstructive sleep apnea. An unexpected cause of insulin resistance and diabetes.” Endocrinol Metab Clin N Am. 2014. (43):187-204.
2. Wang, J, Su M. “Evidence-Based Toxicology: What role might octreotide play in treating diabetic patients with sepsis and hypoglycemia?” ACEP Toxicology Newsletter. 2013 Sept.
3. Wang J, Lakticova V, McCabe A, Amitrano B, Rosen L, Cohen R. “Critical Care Nurses’ Perception of Time Spent at Rapid Responses.” Ann Am Thorac Soc. 2013 Jun;10(3):228-34.
4. Wang J, Greenberg H. “Sleep and the ICU.” Criti Care. The Open Critical Care Medicine Journal. 2013(6).
5. Wang J, Greenberg H. “Status Cataplecticus Precipitated by Abrupt Withdrawal of Venlafaxine.” J Clin Sleep Med. 2013 Jul 15;9(7):715-6.
6. Chandra S, Sica AL, Wang J, Lakticova V, Greenberg HE. “Respiratory Effort Related Arousals Contribute To Sympathetic Modulation of Heart Rate Variability.” Sleep Breath.  2013 Feb 18. Epub ahead of print.
7. Wang J, Chichra A, Koenig S. Epub 2011 Nov 20. “A 72-Year-Old Man With Hypercapneic Respiratory Failure.” Clin Med Insights Circ Respir Pulm Med. 2011;5:81-5.
8. Wang J, Sadoughi A, Dedopoulos S, Talwar  A. April 2011; “Pulmonary Arterial Hypertension as the Initial Presenting Feature of Sclerosis Sine Scleroderma.” Chest, 139:958-961.
9. Chang E, Jacoby S, Wang J, Aghalar J, Hussain R, Pekmezaris R, Wolf-Klein GP. April 2009. “Mandatory Cognitive Screening in Hospitalized Elderly People: Are We Missing the Diagnosis?” Journal of the American Geriatrics Society. 2009 Apr;57(4):746-7.

View more at PubMed

Dr. Koppel’s research program focuses on elucidating the biology of behavioral disturbances in Alzheimer’s disease and the development of novel treatments. Recent work has focused on the endocannabinoid system in Alzheimer’s disease and the contribution of abnormal tau protein deposition to the development of psychotic symptoms.

Indiana University School of Medicine, Indianapolis
Degree: MD

View more at PubMed

Lance Becker, MD, FAHA is a Feinstein Investigator and also serves the chair and professor of emergency medicine at the Hofstra Northwell School of Medicine, chair of the emergency departments at North Shore University Hospital and Long Island Jewish Medical Center. He is an internationally recognized leader in the field of resuscitation, cardiac arrest, and critical care. His most impactful publications focused on question like “where are the survivors (from cardiac arrest)”, creating the Utstein international nomenclature for resuscitation, the original description of the three-phase model of cardiac arrest, reporting disparities in rates of cardiac arrest for minority populations, reappraisal of mouth-to-mouth ventilation, the instillation of AED’s in public settings, ischemia/reperfusion physiology, mitochondrial and metabolic approaches to resuscitation, and the critical descriptions of real-time quality of CPR measures during human cardiac arrest.

At the national level, Dr. Becker has publically advocated for NIH funding for resuscitation research as a leader of the PULSE Initiative that created multiple RFAs totaling over 150M dollars toward research in the last decade. He co-founded and chaired the American Heart Association’s Resuscitation Science Symposium which is the leading international venue for presentation of cutting edge resuscitation science, has served as chair of the AHA’s Peer Review subcommittee, chair of the Basic Life Support Committee, chair of the Cardiopulmonary, Perioperative, and Resuscitation Council, and helped establish the International Liaison Committee on Resuscitation (ILCOR) now responsible for the worlds recommendations on resuscitation practices. Dr. Becker is an elected member of the Institute of Medicine and National Academy of Medicine (IOM/NAM) has been a leader within the IOM/NAM efforts to improve survival from cardiac arrest and helped write the recent report “Strategies to Improve Survival from Cardiac Arrest: A Time to Act” and is currently working to develop a national Collaborative to improve survival from cardiac arrest.

Dr. Becker’s research focuses on the acute resuscitation of dying and critically sick patients. The Feinstein Lab group has developed several advanced animal models of critical illness and cardiac arrest. These experimental models are used to develop new treatments, new advanced biosensors, and to increase our understanding of ischemia/reperfusion physiology.

The laboratory has experience and expertise with the measurements of mitochondrial dysfunction, reactive oxygen and nitrogen species responses to ischemia, apoptotic activation following ischemia, signaling pathways, acute changes in lipid biochemistry following ischemia, changes in oxygen metabolism after ischemia, new cellular cytoprotective strategies and hypothermia protection strategies such as intra-arrest cooling. A unique aspect of the lab is an emphasis on bioengineering; this engineering perspective has been used to better understand the mechanisms of blood flow during CPR, and in using tissue auto-florescence as a measure of redox conditions within the cell and within tissues.

A current focus of his lab at the Feinstein Institute is on developing emergency cardiopulmonary bypass coupled with advanced drugs to save lives of patients who fail traditional ACLS treatment. An advanced animal model of emergency cardiopulmonary bypass has been developed to resuscitate animals following very prolonged periods of cardiac arrest. Experiments with multiple drugs targeted at reperfusion injury have been incorporated to improve neurological function for surviving animals, and a combination of drugs is currently under investigation for possible clinical use in the future.

A recent direction of the lab is to better define changes in oxygen consumption during resuscitation. The laboratory is trying to discern whether or not alterations in carbon metabolism and consumption of oxygen may signal the need for a new paradigm of alternative treatments in critically ill patients.

Joshua Lampe
Email: jlampe@northwell.edu

Koichiro Shinozaki
Email: kshinozaki@northwell.edu

Junhwan Kim
Email: JKim46@northwell.edu

Tai Yin
Email: tyin@northwell.edu

University of Illinois College of Medicine
Degree: MD
1981

University of Illinois
1977
Field of Study: Biochemistry of Graduate Studies

University of Michigan
Degree: BGS
1975

2015 Selected as the 2015 Recipient of the “Asmund S. Laerdal Lecture Award” from the Society of Critical Care Medicine’s Critical Care Congress, Phoenix, Arizona
2014 “Outstanding Contribution in Research” 2014 Award at the American College of Emergency Physicians Annual Meeting, Chicago, IL
2013 Karolinska Institute, Sweden – Elected for The Annual Clinical Science Lecture
2012 Elected to Lifetime Honorary Member, the European Resuscitation Council (ERC) Scientific Congress, Vienna
2012 “Lifetime Achievement Award in Cardiac Resuscitation Science” honored at the American Heart Association’s Resuscitation Science Symposium’s Annual Meeting in Los Angeles, CA
2012 “Hans H. Dahll” Award from the Emergency Cardiovascular Care Citizen CPR Foundation in Orlando, FL
2010 “Giant of Resuscitation” Award from the American Heart, Association’s International Liaison Committee on Resuscitation (ILCOR)
2008 Chairman’s Award of the American Heart Association, honored at the Scientific Sessions’ Annual Meeting in New Orleans, LA
2008 Negovsky Lecture, The European Resuscitation Council 9th European Congress in Ghent, Belgium
2008 Award of Meritorious Achievement, American Heart Association, for co-Founding of the Resuscitation Science Symposium, honored Washington, DC
2007 Elected to the Institute of Medicine, National Academy of Sciences, Washington, DC
2003 Inaugural Fellow, American Heart Association
2003 Dickinson W. Richards Lecturer, American Heart Association Scientific Sessions, Orlando, FL
2001 Asmund Laerdal Award, Scandinavian Society of Anesthesia and Intensive Care, Tromso, Norway
1997 Attending of the Year, Emergency Medicine Housestaff University of Chicago
1981 Honors upon graduation, University of Illinois College of Medicine
1980 Alpha Omega Alpha selected as junior student, University of Illinois College of Medicine

1. Sutton RM, Friess SH, Maltese MR, Naim MY, Bratinov G, Weiland TR, Garuccio M, Bhalala U, Nadkarni VM, Becker LB, Berg RA. “Hemodynamic-directed cardiopulmonary resuscitation during in-hospital cardiac arrest.” Resuscitation. Apr 28, 2014.
2. Friess SH, Sutton RM, French B, Bhalala U, Maltese MR, Naim MY, Bratinov G, Rodriguez SA, Weiland TR, Garuccio M, Nadkarni VM, Becker LB, Berg RA. “Hemodynamic Directed CPR Improves Cerebral Perfusion Pressure and Brain Tissue Oxygenation.” Resuscitation. June 16, 2014.
3. Kim J, Yin T, Ming Y, Zhang W, Shinozaki K, Selak MA, Pappan KL, Lampe JW, Becker LB. “Examination of Physiological Function and Biochemical Disorders in a Rat Model of Prolonged Asphyxia-Inducted Cardiac Arrest followed by Cardio Pulmonary Bypass Resuscitation”. PLOS ONE. 2014 Nov 10;9(11):e112012
4. Sutton RM, Friess SH, Naim MY, Lampe JW, Bratinov G. Weiland TR 3^rd, Garuccio M, Nadkarni VM, Becker LB, Berg RA. “Patient-centric blood pressure-targeted cardiopulmonary resuscitation improves survival from cardiac arrest”. Am J Respir Crit Care Med. December 1, 2014; 190(11):1255-62.
5. Wang H, Guan Y, Widlund AL, Becker LB, Baur JA, Reilly PM, Sims CA. “Resveratrol ameliorates mitochondrial dysfunction but increases the risk of hypoglycemia following hemorrhagic shock”. J Trauma Acute Care Surg. December, 2014; 77(6):926-33.
6. Weiss SL, Selak MA, Tuluc F. Perales Villarroel J, Nadkarni VM, Deutschman CS, Becker LB. “Mitochondrial dysfunction in peripheral blood mononuclear cells in pediatric septic shock”. Pediatr Crit Care Med. January, 2015; 16(1).
7. Shinozaki K, Lampe JW, Wang CH, Yin T, Kim J, Oda S, Hirasawa H, Becker LB. “Developing dual hemofiltration plus cardiopulmonary bypass in rodents”. J Surg Res. 2015 May 1;195(1):196-203.
8. Patil KD, Halperin HR, Becker LB. “Cardiac Arrest: resuscitation and reperfusion”. Circ Res. June 5, 2015; 116(12):2041-9.
9. Yannopoulos D, Aufderheide TP, Abella BS, Duval S, Franscone RJ, Goodloe JM, Mahoney BD, Nadkarni VM, Halperin HR, O’Connor R, Idris AH, Becker LB, Pepe PE. “Quality of CPR: An important effect modifier in cardiac arrest clinical outcomes and intervention effectiveness trials”. Resuscitation. June, 2015
10. Kim J, Lampe JW, Yin T, Shinozaki K, Becker LB “Phospholipid alterations in the brain and heart in a rat model of asphyxia-induced cardiac arrest and cardiopulmonary bypass resuscitation”. Mol Cell Biochem. Jul 17, 2015; DOI: 10.1007/s11010-015-2505-0

View more at PubMed